{"DataElement":{"publicId":"6077832","version":"1","preferredName":"Treatment Cohort Study 10130 Code","preferredDefinition":"The code that represents the information pertaining to protocol 10130 in which subsets of a defined population are identified.","longName":"TX_COHRT_SDY_10130_CD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2497526","version":"1","preferredName":"Treatment Cohort Study","preferredDefinition":"Information pertaining to studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"TX_COHORT_STDY","context":"DCP","contextVersion":"1","ObjectClass":{"publicId":"2416951","version":"1","preferredName":"Therapy","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C15368","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapy","conceptCode":"C15368","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"02DBEE3F-243E-103A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-12","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-12","modifiedBy":"ONEDATA","dateModified":"2005-10-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2497524","version":"1","preferredName":"Cohort Study","preferredDefinition":"Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.","longName":"C15208","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort Study","conceptCode":"C15208","definition":"A research study that compares a particular outcome (such as lung cancer) in groups of individuals who are alike in many ways but differ by a certain characteristic (for example, female nurses who smoke compared with those who do not smoke).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FC9E-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"ONEDATA","dateModified":"2006-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"191BBE49-FCAF-4C77-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-21","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-07-21","modifiedBy":"SOKKERL","dateModified":"2017-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6077827","version":"1","preferredName":"10130 Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic._A symbol or combination of symbols which is assigned to the members of a collection.","longName":"6077827v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"250","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"COHORT D","valueDescription":"Hepatic Function: Severe dysfunction (bilirubin greater than x 3 ULN and up to investigator's discretion; any AST)","ValueMeaning":{"publicId":"6077828","version":"1","preferredName":"Hepatic Function: Severe dysfunction (bilirubin greater than x 3 ULN and up to investigator's discretion; any AST)","longName":"6077828","preferredDefinition":"Hepatic Function: Severe dysfunction (bilirubin greater than x 3 ULN and up to investigator's discretion; any AST)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65A972D8-BDD0-309C-E053-F662850A6367","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"ONEDATA","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67C6D9CA-557F-6A7A-E053-F662850AE70B","beginDate":"2018-03-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-03-19","modifiedBy":"ONEDATA","dateModified":"2018-03-19","deletedIndicator":"No"},{"value":"COHORT C","valueDescription":"Hepatic Function: Moderate dysfunction (bilirubin 1.5 x greater than ULN and less than or equal to 3 x ULN; any AST)","ValueMeaning":{"publicId":"6077829","version":"1","preferredName":"Hepatic Function: Moderate dysfunction (bilirubin 1.5 x greater than ULN and less than or equal to 3 x ULN; any AST)","longName":"6077829","preferredDefinition":"Hepatic Function: Moderate dysfunction (bilirubin 1.5 x greater than ULN and less than or equal to 3 x ULN; any AST)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65A972D8-BDF3-309C-E053-F662850A6367","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"ONEDATA","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67C6D9CA-5593-6A7A-E053-F662850AE70B","beginDate":"2018-03-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-03-19","modifiedBy":"ONEDATA","dateModified":"2018-03-19","deletedIndicator":"No"},{"value":"COHORT B","valueDescription":"Hepatic Function: Mild dysfunction (D1: bilirubin less than or equal to ULN; AST greater than ULN or D2: bilirubin greater than ULN and less than or equal to 1.5 x ULN; any AST)","ValueMeaning":{"publicId":"6077830","version":"1","preferredName":"Hepatic Function: Mild dysfunction (D1: bilirubin less than or equal to ULN; AST greater than ULN or D2: bilirubin greater than ULN and less than or equal to 1.5 x ULN; any AST)","longName":"6077830","preferredDefinition":"Hepatic Function: Mild dysfunction (D1: bilirubin less than or equal to ULN; AST greater than ULN or D2: bilirubin greater than ULN and less than or equal to 1.5 x ULN; any AST)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65A972D8-BE16-309C-E053-F662850A6367","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"ONEDATA","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67C6D9CA-55A7-6A7A-E053-F662850AE70B","beginDate":"2018-03-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-03-19","modifiedBy":"ONEDATA","dateModified":"2018-03-19","deletedIndicator":"No"},{"value":"COHORT A","valueDescription":"Hepatic Function: Normal","ValueMeaning":{"publicId":"6077831","version":"1","preferredName":"Hepatic Function: Normal","longName":"6077831","preferredDefinition":"Hepatic Function: Normal","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"65A972D8-BE39-309C-E053-F662850A6367","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"ONEDATA","dateModified":"2018-02-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"67C6D9CA-55BB-6A7A-E053-F662850AE70B","beginDate":"2018-03-19","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-03-19","modifiedBy":"ONEDATA","dateModified":"2018-03-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4386398","version":"1","preferredName":"Cohort Code","preferredDefinition":"A group of individuals, identified by a common characteristic.:A system of numbered categories for representation of data.","longName":"C61512:C25162","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cohort","conceptCode":"C61512","definition":"A group of individuals, identified by a common characteristic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FE558C16-1C27-C6A8-E040-BB89AD430BEE","latestVersionIndicator":"Yes","beginDate":"2014-07-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2014-07-16","modifiedBy":"ONEDATA","dateModified":"2014-07-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65A972D8-BDB9-309C-E053-F662850A6367","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark.; Curated for Protocol 10166. LS","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Patient Subgroup","type":"Preferred Question Text","description":"Patient Subgroup","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65AC687D-31EC-7B00-E053-F662850AE107","latestVersionIndicator":"Yes","beginDate":"2018-02-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-02-20","modifiedBy":"TAYLORT","dateModified":"2018-11-08","changeDescription":"11/8/18 TT released/PClark.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}